MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

monoclonal antibody

  • FDA Approves Absurd Drug to Delay Diabetes
    FDA Approves Absurd Drug to Delay Diabetes
    A monoclonal antibody injection has been approved for type 1 diabetes. It only costs about $200,000 and comes with a risk of serious side effects. STORY AT-A-GLANCE The U.S. Food ...
    February 13, 2023BY Joseph Mercola
  • FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    The U.S. Food and Drug Administration (FDA) has, for the first time, approved a monoclonal antibody to treat COVID-19 ...
    December 21, 2022BY Mimi Nguyen Ly
  • Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    A cancer trial has reportedly become the first in the world to completely remove the disease in every ...
    June 6, 2022BY Katabella Roberts
  • FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli ...
    February 11, 2022BY Jack Phillips
  • GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    The monoclonal antibody treatment from GlaxoSmithKline (GSK) and Vir BioTechnology protects well against the Omicron subvariant that is ...
    February 10, 2022BY Zachary Stieber
  • FDA Restricts Use of 2 Monoclonal Antibody Treatments
    FDA Restricts Use of 2 Monoclonal Antibody Treatments
    The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
    January 25, 2022BY Mimi Nguyen Ly
  • ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    The federal government's sudden rationing of monoclonal antibody treatments, which are keeping Americans who get COVID-19 out of ...
    September 18, 2021BY Zachary Stieber
TOP NEWS
  • US Forces Strike Iranian Military Infrastructure in 12th Consecutive Night of Attacks
    3hr By Kimberly Hayek
    US Forces Strike Iranian Military Infrastructure in 12th Consecutive Night of Attacks
  • Company Disputes New Jersey’s Claim About ‘Serious Software Error’ That Added Noncitizens to Voter Roll
    3hr By Timothy Frudd
    Company Disputes New Jersey’s Claim About ‘Serious Software Error’ That Added Noncitizens to Voter Roll
  • Here’s Who Won Key House Primaries in Arizona
    4hr By Nathan Worcester
    Here’s Who Won Key House Primaries in Arizona
  • FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
    6hr By Kimberly Hayek
    FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
  • Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
    7hr By Travis Gillmore
    Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
  • 124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
    8hr By Arthur Zhang
    124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
  • Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
    8hr By Epoch Video
    Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    8hr By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    9hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    10hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top